Tuvalu Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tuvalu Health Digest.

Press releases published on October 27, 2026

Oct. 27, 2026

Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain

Indeterminate GlobeNewswire

Oct. 27, 2026

Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire

Oct. 27, 2026

NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Oct. 27, 2026

Merakris Advances Potentially Pivotal MTX-001 Phase 2/3 Strategy Following FDA Pre-IND Meeting

Indeterminate GlobeNewswire

Oct. 27, 2026

Winona Baby Joins ISAD 2026 as the Only Invited Chinese Infant Skincare Brand

Indeterminate GlobeNewswire

Oct. 27, 2026

As defence spending rises, ALS community calls for greater federal investment in ALS research

Indeterminate GlobeNewswire

Oct. 27, 2026

Alors que les dépenses en défense augmentent, la communauté SLA réclame un investissement fédéral accru dans la recherche sur la SLA

Indeterminate GlobeNewswire

Oct. 27, 2026

Aclaris Therapeutics Announces Positive Phase 1b Proof-of-Concept Primary Analysis Results for its Anti-TSLP/IL-4Rα Bispecific ATI-052 in Atopic Dermatitis (AD) and Asthma

Indeterminate GlobeNewswire

Oct. 27, 2026

Anteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium

Indeterminate GlobeNewswire

Oct. 27, 2026

Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 27, 2026

Immuron continued quarterly sales growth

Indeterminate GlobeNewswire

Oct. 27, 2026

Newsweek stuft das KFSH hinsichtlich digitaler Reife und KI unter die besten 4 % der weltweit führenden „Smart Hospitals“ ein

Indeterminate GlobeNewswire

Oct. 27, 2026

Newsweek classe le KFSH parmi les 4 % d’hôpitaux les plus avancés au monde en matière de maturité numérique et d’IA

Indeterminate GlobeNewswire

Oct. 27, 2026

Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices

Indeterminate GlobeNewswire

Oct. 27, 2026

Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Cellectis présente de nouvelles données précliniques démontrant une édition efficace du gène APOC3 et une réduction marquée des triglycérides avec .HEAL-101 à l’ESGCT 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome, with new preclinical and epidemiological data presented at ASN Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

KFSH Strengthens Patient-Centered Care With ICHOM Accreditation

Indeterminate GlobeNewswire